Literature DB >> 24464050

Neuronal nicotinic acetylcholine receptors are important targets for alcohol reward and dependence.

Jie Wu1, Ming Gao2, Devin H Taylor2.   

Abstract

Neuronal nicotinic acetylcholine receptors are important targets for alcohol reward and dependence. Alcoholism is a serious public health problem and has been identified as the third major cause of preventable mortality in the world. Worldwide, about 2 billion people consume alcohol, with 76.3 million having diagnosable alcohol use disorders. Alcohol is currently responsible for the death of 4% of adults worldwide (about 2.5 million deaths each year), and this number will be significantly increased by 2020 unless effective action is taken. Alcohol is the most commonly abused substance by humans. Ethanol (EtOH) is the intoxicating agent in alcoholic drinks that can lead to abuse and dependence. Although it has been extensively studied, the mechanisms of alcohol reward and dependence are still poorly understood. The major reason is that, unlike other addictive drugs (eg, morphine, cocaine or nicotine) that have specific molecular targets, EtOH affects much wider neuronal functions. These functions include phospholipid membranes, various ion channels and receptors, synaptic and network functions, and intracellular signaling molecules. The major targets in the brain that mediate EtOH's effects remain unclear. This knowledge gap results in a therapeutic barrier in the treatment of alcoholism. Interestingly, alcohol and nicotine are often co-abused, which suggests that neuronal nicotinic acetylcholine receptors (nAChRs), the molecular targets for nicotine, may also contribute to alcohol's abusive properties. Here, we briefly summarize recent lines of evidence showing how EtOH modulates nAChRs in the mesolimbic pathway, which provides a perspective that nAChRs are important targets mediating alcohol abuse.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24464050      PMCID: PMC4647894          DOI: 10.1038/aps.2013.181

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  46 in total

Review 1.  Actual causes of death in the United States, 2000.

Authors:  Ali H Mokdad; James S Marks; Donna F Stroup; Julie L Gerberding
Journal:  JAMA       Date:  2004-03-10       Impact factor: 56.272

2.  Modulation of ethanol drinking-in-the-dark by mecamylamine and nicotinic acetylcholine receptor agonists in C57BL/6J mice.

Authors:  Linzy M Hendrickson; Rubing Zhao-Shea; Andrew R Tapper
Journal:  Psychopharmacology (Berl)       Date:  2009-02-27       Impact factor: 4.530

3.  Ethanol elevates accumbal dopamine levels via indirect activation of ventral tegmental nicotinic acetylcholine receptors.

Authors:  Mia Ericson; Anna Molander; Elin Löf; Jörgen A Engel; Bo Söderpalm
Journal:  Eur J Pharmacol       Date:  2003-04-25       Impact factor: 4.432

Review 4.  Neurobiology of alcohol dependence: focus on motivational mechanisms.

Authors:  Nicholas W Gilpin; George F Koob
Journal:  Alcohol Res Health       Date:  2008

Review 5.  Nicotinic acetylcholine receptors as targets for antidepressants.

Authors:  R D Shytle; A A Silver; R J Lukas; M B Newman; D V Sheehan; P R Sanberg
Journal:  Mol Psychiatry       Date:  2002       Impact factor: 15.992

6.  Association of nAChR gene haplotypes with heavy alcohol use and body mass.

Authors:  Sara Landgren; Jörgen A Engel; Malin E Andersson; Arturo Gonzalez-Quintela; Joaquin Campos; Staffan Nilsson; Henrik Zetterberg; Kaj Blennow; Elisabet Jerlhag
Journal:  Brain Res       Date:  2009-08-19       Impact factor: 3.252

7.  Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men.

Authors:  Kenneth J Mukamal; Katherine M Conigrave; Murray A Mittleman; Carlos A Camargo; Meir J Stampfer; Walter C Willett; Eric B Rimm
Journal:  N Engl J Med       Date:  2003-01-09       Impact factor: 91.245

8.  Nicotinic acetylcholine receptors containing the α6 subunit contribute to ethanol activation of ventral tegmental area dopaminergic neurons.

Authors:  Liwang Liu; Rubing Zhao-Shea; J Michael McIntosh; Andrew R Tapper
Journal:  Biochem Pharmacol       Date:  2013-06-26       Impact factor: 5.858

9.  Association of gamma-aminobutyric acid A receptor α2 gene (GABRA2) with alcohol use disorder.

Authors:  Dawei Li; Arvis Sulovari; Chao Cheng; Hongyu Zhao; Henry R Kranzler; Joel Gelernter
Journal:  Neuropsychopharmacology       Date:  2013-10-18       Impact factor: 7.853

10.  Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei.

Authors:  R Klink; A de Kerchove d'Exaerde ; M Zoli; J P Changeux
Journal:  J Neurosci       Date:  2001-03-01       Impact factor: 6.167

View more
  16 in total

1.  Mecamylamine treatment for alcohol dependence: a randomized controlled trial.

Authors:  Ismene L Petrakis; Elizabeth Ralevski; Ralitza Gueorguieva; Stephanie S O'Malley; Albert Arias; Kevin A Sevarino; Jane S Jane; Erin O'Brien; John H Krystal
Journal:  Addiction       Date:  2017-10-12       Impact factor: 6.526

Review 2.  Interactions between nicotine and drugs of abuse: a review of preclinical findings.

Authors:  Stephen J Kohut
Journal:  Am J Drug Alcohol Abuse       Date:  2016-09-02       Impact factor: 3.829

3.  Modeling gene regulation from paired expression and chromatin accessibility data.

Authors:  Zhana Duren; Xi Chen; Rui Jiang; Yong Wang; Wing Hung Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-02       Impact factor: 11.205

4.  Bivariate genome-wide association analyses identified genetic pleiotropic effects for bone mineral density and alcohol drinking in Caucasians.

Authors:  Shan Lu; Lan-Juan Zhao; Xiang-Ding Chen; Christopher J Papasian; Ke-Hao Wu; Li-Jun Tan; Zhuo-Er Wang; Yu-Fang Pei; Qing Tian; Hong-Wen Deng
Journal:  J Bone Miner Metab       Date:  2016-12-23       Impact factor: 2.626

5.  Behavioral Deficits Following Withdrawal from Chronic Ethanol Are Influenced by SLO Channel Function in Caenorhabditis elegans.

Authors:  Luisa L Scott; Scott J Davis; Rachel C Yen; Greg J Ordemann; Sarah K Nordquist; Deepthi Bannai; Jonathan T Pierce
Journal:  Genetics       Date:  2017-05-25       Impact factor: 4.562

6.  Moderators of Varenicline Treatment Effects in a Double-Blind, Placebo-Controlled Trial for Alcohol Dependence: An Exploratory Analysis.

Authors:  Daniel E Falk; I-Jen P Castle; Megan Ryan; Joanne Fertig; Raye Z Litten
Journal:  J Addict Med       Date:  2015 Jul-Aug       Impact factor: 3.702

7.  Age-related differences in the effect of chronic alcohol on cognition and the brain: a systematic review.

Authors:  Lauren Kuhns; Emese Kroon; Heidi Lesscher; Gabry Mies; Janna Cousijn
Journal:  Transl Psychiatry       Date:  2022-08-25       Impact factor: 7.989

8.  A Phase 2, Double-Blind, Placebo-Controlled Randomized Trial Assessing the Efficacy of ABT-436, a Novel V1b Receptor Antagonist, for Alcohol Dependence.

Authors:  Megan L Ryan; Daniel E Falk; Joanne B Fertig; Beatrice Rendenbach-Mueller; David A Katz; Katherine A Tracy; Eric C Strain; Kelly E Dunn; Kyle Kampman; Elizabeth Mahoney; Domenic A Ciraulo; Laurie Sickles-Colaneri; Nassima Ait-Daoud; Bankole A Johnson; Janet Ransom; Charles Scott; George F Koob; Raye Z Litten
Journal:  Neuropsychopharmacology       Date:  2016-09-23       Impact factor: 7.853

Review 9.  Recent Advances in Nicotinic Receptor Signaling in Alcohol Abuse and Alcoholism.

Authors:  Shafiqur Rahman; Eric A Engleman; Richard L Bell
Journal:  Prog Mol Biol Transl Sci       Date:  2015-11-03       Impact factor: 3.622

Review 10.  Role of microRNAs in the pathophysiology of addiction.

Authors:  Austin M Gowen; Katherine E Odegaard; Jordan Hernandez; Subhash Chand; Sneh Koul; Gurudutt Pendyala; Sowmya V Yelamanchili
Journal:  Wiley Interdiscip Rev RNA       Date:  2020-12-17       Impact factor: 9.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.